Ratings by Lake Street (Thomas Flaten)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/23/2026 | Vivani Medical, Inc. | VANI | New Coverage | Buy (N/A) |
1.13 (1.26) |
11.5% | Details | |
| 5/22/2026 | Rapid Micro Biosystems Inc | RPID | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2026 | MDxHealth SA | MDXH | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2026 | Assertio Therapeutics | ASRT | Maintain | Hold (N/A) |
|
Details | ||
| 5/12/2026 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2026 | Assertio Therapeutics | ASRT | Downgrade | Hold (Buy) |
18.41 (23.50) |
27.65% | Details | |
| 3/9/2026 | Evaxion Biotech | EVAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2026 | Insight Molecular Diagnostics Inc. | IMDX | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2026 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2026 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2025 | Pelthos Therapeutics | PTHS | New Coverage | Buy (N/A) |
25.14 (25.77) |
2.51% | Details | |
| 12/1/2025 | Connect Biopharma Holdings Ltd | CNTB | New Coverage | Buy (N/A) |
2.81 (2.46) |
-12.46% | Details | |
| 11/13/2025 | MDxHealth SA | MDXH | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2025 | Journey Medical Corp. | DERM | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2025 | Rapid Micro Biosystems Inc | RPID | New Coverage | Buy (N/A) |
4.08 (1.72) |
-57.84% | Details | |
| 7/18/2025 | DiaMedica Therapeutics Inc. | DMAC | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2025 | Aytu Biosciences | AYTU | New Coverage | Buy (N/A) |
2.18 (2.16) |
-0.92% | Details | |
| 5/14/2025 | Biodesix | BDSX | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2025 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2025 | OncoCyte Corp | OCX | New Coverage | Buy (N/A) |
3.22 (3.20) |
-0.62% | Details | |
| 3/20/2025 | Optinose | OPTN | Downgrade | Hold (Buy) |
6.00 (9.60) |
60% | Details | |
| 3/10/2025 | Checkpoint Therapeutics | CKPT | Downgrade | Hold (Buy) |
2.47 (4.26) |
72.47% | Details | |
| 3/7/2025 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2025 | Evaxion Biotech | EVAX | Maintain | Buy (N/A) |
|
Details | ||
| 1/16/2025 | Optinose | OPTN | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2024 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2024 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2024 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2024 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2024 | MDxHealth SA | MDXH | New Coverage | Buy (N/A) |
2.04 (0.48) |
-76.47% | Details | |
| 9/6/2024 | Journey Medical Corp. | DERM | New Coverage | Buy (N/A) |
4.70 (7.09) |
50.85% | Details | |
| 8/19/2024 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2024 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2024 | Optinose | OPTN | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2024 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2024 | Personalis | PSNL | New Coverage | Buy (N/A) |
1.36 (13.62) |
901.47% | Details | |
| 4/19/2024 | DermTech Inc. | DMTK | Downgrade | Hold (Buy) |
0.59 (0.09) |
-84.75% | Details | |
| 3/18/2024 | Optinose | OPTN | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2024 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2024 | Assertio Therapeutics | ASRT | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2024 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2024 | Achieve Life Sciences | ACHV | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2024 | DermTech Inc. | DMTK | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2024 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2024 | DermTech Inc. | DMTK | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2024 | Assertio Therapeutics | ASRT | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2023 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2023 | Better Therapeutics | BTTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2023 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2023 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Assertio Therapeutics | ASRT | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | DermTech Inc. | DMTK | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2023 | Better Therapeutics | BTTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2023 | Optinose | OPTN | New Coverage | Buy (N/A) |
1.30 (9.60) |
638.46% | Details | |
| 8/17/2023 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2023 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | Better Therapeutics | BTTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2023 | Assertio Therapeutics | ASRT | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2023 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 5/31/2023 | Achieve Life Sciences | ACHV | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2023 | CTI BioPharma | CTIC | Downgrade | Hold (Buy) |
4.82 (9.09) |
88.59% | Details | |
| 5/10/2023 | Assertio Therapeutics | ASRT | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2023 | Evaxion Biotech | EVAX | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2023 | Better Therapeutics | BTTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2023 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2023 | Evaxion Biotech | EVAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2023 | Assertio Therapeutics | ASRT | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2023 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2022 | OncoCyte Corp | OCX | Downgrade | Hold (Buy) |
0.47 (3.20) |
580.85% | Details | |
| 11/17/2022 | Ensysce Biosciences Inc. | ENSC | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | DermTech Inc. | DMTK | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2022 | OncoCyte Corp | OCX | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2022 | DiaMedica Therapeutics Inc. | DMAC | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2022 | Brickell Biotech Inc. | BBI | Downgrade | Hold (Buy) |
0.21 (2.35) |
1019.05% | Details | |
| 3/15/2022 | Brickell Biotech Inc. | BBI | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2022 | DiaMedica Therapeutics Inc. | DMAC | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2022 | OncoCyte Corp | OCX | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2021 | DiaMedica Therapeutics Inc. | DMAC | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2021 | Castle Biosciences | CSTL | New Coverage | Buy (N/A) |
68.07 (24.11) |
-64.58% | Details | |
| 2/3/2021 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2020 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2020 | Brickell Biotech Inc. | BBI | New Coverage | Buy (N/A) |
0.82 (2.35) |
186.59% | Details | |
| 5/20/2020 | Biofrontera AG | BFRA | Upgrade | Buy (Hold) |
6.71 (2.67) |
-60.21% | Details | |
| 2/24/2020 | BioLife Solutions | BLFS | New Coverage | Buy (N/A) |
15.63 (28.11) |
79.85% | Details | |
| 12/5/2019 | DermTech Inc. | DMTK | New Coverage | Buy (N/A) |
7.60 (0.59) |
-92.24% | Details | |
| 5/29/2019 | Checkpoint Therapeutics | CKPT | New Coverage | Buy (N/A) |
4.35 (4.26) |
-2.07% | Details | |
| 4/4/2019 | ZIOPHARM Oncology | ZIOP | New Coverage | Buy (N/A) |
4.13 (0.87) |
-78.93% | Details | |
| 3/5/2019 | DiaMedica Therapeutics Inc. | DMAC | New Coverage | Buy (N/A) |
3.45 (7.62) |
120.87% | Details | |
| 3/5/2019 | CTI BioPharma | CTIC | New Coverage | Buy (N/A) |
1.10 (9.09) |
726.36% | Details | |
| 1/29/2019 | OncoCyte Corp | OCX | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2019 | Aquestive Therapeutics | AQST | New Coverage | Buy (N/A) |
6.30 (4.18) |
-33.65% | Details | |
| 12/19/2018 | OncoCyte Corp | OCX | New Coverage | Buy (N/A) |
1.53 (3.20) |
109.15% | Details |
